Herbert Smith Freehills advised CICC and CSCI on the deal while O’Melveny recently represented 3D Medicines. CICC and CSCI acted as joint sponsors of 3D Medicines...
3D Medicines Inc.’s Listing on the Stock Exchange of Hong Kong
Lygend Resources & Technology Co., Ltd.’s Mainboard Listing on the Stock Exchange of Hong Kong
Herbert Smith Freehills advised CICC and CMB International as joint sponsors and underwriters. T&C Law Firm advised Lygend on the deal. Lygend is Hong Kong’s 6th...
Hangzhou SF Intra-city Industrial Co., Ld.’s Mainboard Listing on the Hong Kong Stock Exchange
Herbert Smith Freehills advised the joint sponsors involved in the IPO. Clifford Chance advised SF Intra-City Industrial Co. Ltd. SF Intra-city operates China’s largest third-party on-demand...
UNQ Holdings Limited’s US$46.86 Million Initial Public Offering
Herbert Smith Freehills has advised CICC on the deal. UNQ Holdings Limited (02177.HK) has been listed on the Stock Exchange of Hong Kong. CICC acted as sole...